A Senate Committee has passed a bipartisan FDA reauthorization bill that includes several provisions aimed at improving drug safety, bringing breakthrough treatments to patients more quickly, advancing medical device innovations and preventing critical drug shortages.
Read the full report in Becker’s Hospital Review on the FDA reauthorization bill.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
